30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Biotechnology & Medical Research

Novelion Therapeutics Inc (NVLNF)

Track

Stock chart
Ticker: NVLNF Exchange: OTC
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
STONEPINE CAPITAL, L.P.
1 purchase — total 700 USD
Buy 12 Dec 2019
Value US$2,716,053.47 | Price 426.36 | Shares 38,424
Buy 11 Dec 2019
Value US$100,488.26 | Price 50.33 | Shares 62,142
Buy 10 Dec 2019
Value US$3,597.70 | Price 0.69 | Shares 5,202
Buy 9 Dec 2019
Value US$3,150.00 | Price 0.70 | Shares 4,500
Buy 6 Dec 2019
Value US$28.00 | Price 0.70 | Shares 40
Buy 5 Dec 2019
Value US$3,612.00 | Price 0.70 | Shares 5,160
Buy 22 Nov 2019
Value US$67,033.35 | Price 0.75 | Shares 89,845
Buy 11 Oct 2019
Value US$64,900.00 | Price 0.65 | Shares 100,000
Sale 27 Dec 2018
Value US$85,140.00 | Price 0.85 | Shares 100,000
Sale 27 Dec 2018
Value US$48,138.92 | Price 0.85 | Shares 56,316
Sale 27 Dec 2018
Value US$13,028.44 | Price 0.88 | Shares 14,800
Sale 26 Dec 2018
Value US$27,868.48 | Price 0.91 | Shares 30,726
Sale 26 Dec 2018
Value US$26,037.22 | Price 0.91 | Shares 28,745
Sale 26 Dec 2018
Value US$11,108.29 | Price 0.91 | Shares 12,219
Sale 26 Dec 2018
Value US$95,832.80 | Price 0.87 | Shares 109,900
Sale 26 Dec 2018
Value US$11,302.11 | Price 0.91 | Shares 12,450
Sale 26 Dec 2018
Value US$81,446.91 | Price 0.98 | Shares 83,245
Sale 26 Dec 2018
Value US$1,119.00 | Price 0.93 | Shares 1,200
Sale 24 Dec 2018
Value US$392.00 | Price 0.98 | Shares 400
Buy 12 Jun 2017
Value US$22,750.00 | Price 9.10 | Shares 2,500
Buy 15 May 2017
Value US$3,230.95 | Price 8.95 | Shares 361
Buy 15 Sep 2016
Value US$23,138.40 | Price 1.55 | Shares 14,928
Buy 14 Sep 2016
Value US$88,269.99 | Price 1.55 | Shares 56,864
Buy 13 Sep 2016
Value US$95,166.08 | Price 1.54 | Shares 61,704
Buy 29 Dec 2015
Value US$996.00 | Price 2.49 | Shares 400
Buy 29 Dec 2015
Value US$45,000.00 | Price 2.50 | Shares 18,000
Buy 16 Jun 2015
Value US$999,360.00 | Price 3.47 | Shares 288,000
Sale 16 Jun 2015
Value US$30,771,426.46 | Price 3.47 | Shares 8,865,036
Sale 16 Jun 2015
Value US$26,252,113.27 | Price 3.47 | Shares 7,563,053
Buy 22 Dec 2014
Value US$3,258.00 | Price 3.62 | Shares 900
Buy 22 Dec 2014
Value US$2,172.00 | Price 3.62 | Shares 600
Buy 22 Dec 2014
Value US$15,928.00 | Price 3.62 | Shares 4,400
Buy 22 Dec 2014
Value US$3,258.00 | Price 3.62 | Shares 900
Buy 22 Dec 2014
Value US$2,177.94 | Price 3.63 | Shares 600
Buy 22 Dec 2014
Value US$3,266.91 | Price 3.63 | Shares 900
Buy 19 Dec 2014
Value US$5,865.00 | Price 3.45 | Shares 1,700
Buy 18 Dec 2014
Value US$72,000.00 | Price 3.60 | Shares 20,000
Sale 11 Jul 2014
Value US$5,800,000.00 | Price 5.80 | Shares 1,000,000
Sale 1 Jul 2013
Value US$1,268,227.10 | Price 4.39 | Shares 288,890
Buy 28 Jun 2013
Value US$130,800.00 | Price 4.36 | Shares 30,000
Sale 14 May 2013
Value US$796.00 | Price 7.96 | Shares 100
Sale 14 May 2013
Value US$78,705.00 | Price 7.95 | Shares 9,900
Buy 13 May 2013
Value US$79,700.00 | Price 7.97 | Shares 10,000
Sale 3 May 2013
Value US$706,500.00 | Price 7.85 | Shares 90,000
Buy 3 May 2013
Value US$159,200.00 | Price 7.96 | Shares 20,000
Sale 28 Dec 2012
Value US$375,315.00 | Price 7.51 | Shares 50,000
Sale 27 Dec 2012
Value US$1,354,734.00 | Price 7.53 | Shares 180,000
Planned sale 12 Dec 2012
Value US$40,100.00 | Price 8.02 | Shares 5,000
Planned sale 28 Nov 2012
Value US$39,400.00 | Price 7.88 | Shares 5,000
Planned sale 20 Nov 2012
Value US$39,050.00 | Price 7.81 | Shares 5,000
Planned sale 1 Nov 2012
Value US$37,600.00 | Price 7.52 | Shares 5,000
Planned sale 22 Oct 2012
Value US$38,600.00 | Price 7.72 | Shares 5,000
Planned sale 5 Oct 2012
Value US$38,600.00 | Price 7.72 | Shares 5,000
Planned sale 18 Sep 2012
Value US$37,850.00 | Price 7.57 | Shares 5,000
Planned sale 5 Sep 2012
Value US$37,750.00 | Price 7.55 | Shares 5,000
Planned sale 20 Aug 2012
Value US$38,350.00 | Price 7.67 | Shares 5,000
Sale 13 Aug 2012
Value US$583,928.68 | Price 7.58 | Shares 77,007
Sale 8 Aug 2012
Value US$180,495.05 | Price 7.85 | Shares 22,993
Planned sale 8 Aug 2012
Value US$39,600.00 | Price 7.92 | Shares 5,000
Sale 3 Aug 2012
Value US$548,730.00 | Price 8.19 | Shares 67,000
Planned sale 24 Jul 2012
Value US$41,400.00 | Price 8.28 | Shares 5,000
Sale 9 Jul 2012
Value US$152,460.00 | Price 7.62 | Shares 20,000
Sale 9 Jul 2012
Value US$422,290.56 | Price 7.62 | Shares 55,450
Planned sale 9 Jul 2012
Value US$37,650.00 | Price 7.53 | Shares 5,000
Planned sale 21 Jun 2012
Value US$38,250.00 | Price 7.65 | Shares 5,000
Planned sale 15 Jun 2012
Value US$37,350.00 | Price 7.47 | Shares 5,000
Buy 16 May 2012
Value US$333,340.00 | Price 6.67 | Shares 50,000
Buy 15 May 2012
Value US$16,072.49 | Price 6.56 | Shares 2,450
Sale 29 Nov 2011
Value US$134,522.00 | Price 6.73 | Shares 20,000
Sale 29 Nov 2011
Value US$30,120.20 | Price 6.85 | Shares 4,400
Sale 28 Nov 2011
Value US$39,360.72 | Price 7.03 | Shares 5,600
Buy 23 Nov 2011
Value US$8,813.09 | Price 6.78 | Shares 1,300
Buy 23 Nov 2011
Value US$14,897.30 | Price 6.77 | Shares 2,200
Buy 23 Nov 2011
Value US$10,142.85 | Price 6.76 | Shares 1,500
Buy 22 Nov 2011
Value US$2,782.68 | Price 6.96 | Shares 400
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2019-12-12 2019-12-12 B Purchase STONEPINE CAPITAL, L.P. Large shareholder
38,424 -11.1%
426.36
US$2,716,053 		38,424 -11.1% 426.36 US$2,716,053
2019-12-12 2019-12-11 B Purchase STONEPINE CAPITAL, L.P. Large shareholder
62,142 +40.0%
50.33
US$100,488 		62,142 +40.0% 50.33 US$100,488
2019-12-12 2019-12-10 B Purchase STONEPINE CAPITAL, L.P. Large shareholder
90,213 +23.3%
193.69
US$4,937,356 		90,213 +23.3% 193.69 US$4,937,356
2019-12-09 2019-12-09 B Purchase STONEPINE CAPITAL, L.P. Large shareholder
4,500 +0.1%
0.70
US$3,150 		4,500 +0.1% 0.70 US$3,150
2019-12-09 2019-12-06 B Purchase STONEPINE CAPITAL, L.P. Large shareholder
40 +0.0%
0.70
US$28 		40 +0.0% 0.70 US$28
2019-12-09 2019-12-05 B Purchase STONEPINE CAPITAL, L.P. Large shareholder
5,160 +0.1%
0.70
US$3,612 		5,160 +0.1% 0.70 US$3,612
2019-11-26 2019-11-22 B Purchase STONEPINE CAPITAL, L.P. Large shareholder
89,845 +2.4%
0.75
US$67,033 		89,845 +2.4% 0.75 US$67,033
2019-10-16 2019-10-11 B Purchase
STONEPINE CAPITAL, L.P.
Large shareholder
100,000 +2.7%
0.65
US$64,900 		100,000 +2.7% 0.65 US$64,900
2018-12-27 2018-12-27 S Sale Broadfin Healthcare Master Fund Ltd Large shareholder
100,000 -6.3%
0.85
US$85,140 		100,000 -6.3% 0.85 US$85,140
2018-12-27 2018-12-27 S Sale Broadfin Healthcare Master Fund Ltd Large shareholder
56,316 -3.4%
0.85
US$48,139 		56,316 -3.4% 0.85 US$48,139
2018-12-27 2018-12-27 S Sale Broadfin Healthcare Master Fund Ltd Large shareholder
14,800 -0.9%
0.88
US$13,028 		14,800 -0.9% 0.88 US$13,028
2018-12-27 2018-12-26 S Sale Broadfin Healthcare Master Fund Ltd Large shareholder
30,726 -1.8%
0.91
US$27,868 		30,726 -1.8% 0.91 US$27,868
2018-12-27 2018-12-26 S Sale Broadfin Healthcare Master Fund Ltd Large shareholder
28,745 -1.7%
0.91
US$26,037 		28,745 -1.7% 0.91 US$26,037
2018-12-27 2018-12-26 S Sale Broadfin Healthcare Master Fund Ltd Large shareholder
12,219 -0.7%
0.91
US$11,108 		12,219 -0.7% 0.91 US$11,108
2018-12-27 2018-12-26 S Sale Broadfin Healthcare Master Fund Ltd Large shareholder
109,900 -5.9%
0.87
US$95,833 		109,900 -5.9% 0.87 US$95,833
2018-12-27 2018-12-26 S Sale Broadfin Healthcare Master Fund Ltd Large shareholder
12,450 -0.7%
0.91
US$11,302 		12,450 -0.7% 0.91 US$11,302
2018-12-27 2018-12-26 S Sale Broadfin Healthcare Master Fund Ltd Large shareholder
83,245 -4.3%
0.98
US$81,447 		83,245 -4.3% 0.98 US$81,447
2018-12-27 2018-12-26 S Sale Broadfin Healthcare Master Fund Ltd Large shareholder
1,200 -0.1%
0.93
US$1,119 		1,200 -0.1% 0.93 US$1,119
2018-12-27 2018-12-24 S Sale Broadfin Healthcare Master Fund Ltd Large shareholder
400 -0.0%
0.98
US$392 		400 -0.0% 0.98 US$392
2017-06-13 2017-06-12 B Purchase Stern Donald K
2,500 +inf%
9.10
US$22,750 		2,500 +inf% 9.10 US$22,750
2017-05-17 2017-05-15 B Purchase Aryeh Jason Non-Executive Director
361 +0.1%
8.95
US$3,231 		361 +0.1% 8.95 US$3,231
2016-09-15 2016-09-15 B Purchase STONEPINE CAPITAL, L.P. Large shareholder
14,928 +0.3%
1.55
US$23,138 		14,928 +0.3% 1.55 US$23,138
2016-09-15 2016-09-14 B Purchase STONEPINE CAPITAL, L.P. Large shareholder
56,864 +1.0%
1.55
US$88,270 		56,864 +1.0% 1.55 US$88,270
2016-09-15 2016-09-13 B Purchase STONEPINE CAPITAL, L.P. Large shareholder
61,704 +1.1%
1.54
US$95,166 		61,704 +1.1% 1.54 US$95,166
2015-12-30 2015-12-29 B Purchase Aryeh Jason Non-Executive Director
400 +0.1%
2.49
US$996 		400 +0.1% 2.49 US$996
2015-12-30 2015-12-29 B Purchase Aryeh Jason Non-Executive Director
18,000 +4.1%
2.50
US$45,000 		18,000 +4.1% 2.50 US$45,000
2015-06-18 2015-06-16 B Purchase Aryeh Jason Non-Executive Director
288,000 +inf%
3.47
US$999,360 		288,000 +inf% 3.47 US$999,360
2015-06-17 2015-06-16 S Sale AXIAL CAPITAL MANAGEMENT, LLC Large shareholder
8,865,036 -100.0%
3.47
US$30,771,426 		8,865,036 -100.0% 3.47 US$30,771,426
2015-06-17 2015-06-16 S Sale Axial Capital Master, L.P. Large shareholder
7,563,053 -100.0%
3.47
US$26,252,113 		7,563,053 -100.0% 3.47 US$26,252,113
2014-12-23 2014-12-22 B Purchase KOZARICH JOHN W Non-Executive Director
900 +4.3%
3.62
US$3,258 		900 +4.3% 3.62 US$3,258
2014-12-23 2014-12-22 B Purchase KOZARICH JOHN W Non-Executive Director
600 +2.9%
3.62
US$2,172 		600 +2.9% 3.62 US$2,172
2014-12-23 2014-12-22 B Purchase KOZARICH JOHN W Non-Executive Director
4,400 +27.3%
3.62
US$15,928 		4,400 +27.3% 3.62 US$15,928
2014-12-23 2014-12-22 B Purchase KOZARICH JOHN W Non-Executive Director
900 +5.9%
3.62
US$3,258 		900 +5.9% 3.62 US$3,258
2014-12-23 2014-12-22 B Purchase KOZARICH JOHN W Non-Executive Director
600 +4.1%
3.63
US$2,178 		600 +4.1% 3.63 US$2,178
2014-12-23 2014-12-22 B Purchase KOZARICH JOHN W Non-Executive Director
900 +6.6%
3.63
US$3,267 		900 +6.6% 3.63 US$3,267
2014-12-23 2014-12-19 B Purchase KOZARICH JOHN W Non-Executive Director
1,700 +14.2%
3.45
US$5,865 		1,700 +14.2% 3.45 US$5,865
2014-12-19 2014-12-18 B Purchase Meckler Jeffrey A Non-Executive Director
20,000 +38.5%
3.60
US$72,000 		20,000 +38.5% 3.60 US$72,000
2014-07-15 2014-07-11 S Sale NB Public Equity K/S Large shareholder
1,000,000 -13.4%
5.80
US$5,800,000 		1,000,000 -13.4% 5.80 US$5,800,000
2013-07-02 2013-07-01 S Sale Axial Capital Master, L.P. Large shareholder
288,890 -3.7%
4.39
US$1,268,227 		288,890 -3.7% 4.39 US$1,268,227
2013-07-01 2013-06-28 B Purchase Meckler Jeffrey A Non-Executive Director
30,000 +150.0%
4.36
US$130,800 		30,000 +150.0% 4.36 US$130,800
2013-05-15 2013-05-14 S Sale Jagpal Sukhi

Chief Financial Officer

Officer
100 -7.7%
7.96
US$796 		100 -7.7% 7.96 US$796
2013-05-15 2013-05-14 S Sale Jagpal Sukhi

Chief Financial Officer

Officer
9,900 -88.4%
7.95
US$78,705 		9,900 -88.4% 7.95 US$78,705
2013-05-14 2013-05-13 B Purchase KOZARICH JOHN W Non-Executive Director
10,000 +inf%
7.97
US$79,700 		10,000 +inf% 7.97 US$79,700
2013-05-06 2013-05-03 S Sale Lussow Alexander R

Sr. VP, Bus. Dev. & Comm. Op.

Officer
90,000 -81.8%
7.85
US$706,500 		90,000 -81.8% 7.85 US$706,500
2013-05-06 2013-05-03 B Purchase Meckler Jeffrey A Non-Executive Director
20,000 +inf%
7.96
US$159,200 		20,000 +inf% 7.96 US$159,200
2012-12-28 2012-12-28 S Sale Lussow Alexander R

Sr. VP, Bus. Dev. & Comm. Op.

Officer
50,000 -71.4%
7.51
US$375,315 		50,000 -71.4% 7.51 US$375,315
2012-12-28 2012-12-27 S Sale Lussow Alexander R

Sr. VP, Bus. Dev. & Comm. Op.

Officer
180,000 -90.0%
7.53
US$1,354,734 		180,000 -90.0% 7.53 US$1,354,734
2012-12-13 2012-12-12 PlS Planned sale Lussow Alexander R

Sr. VP, Bus. Dev. & Comm. Op.

Officer
5,000 -20.0%
8.02
US$40,100 		5,000 -20.0% 8.02 US$40,100
2012-11-29 2012-11-28 PlS Planned sale Lussow Alexander R

Sr. VP, Bus. Dev. & Comm. Op.

Officer
5,000 -20.0%
7.88
US$39,400 		5,000 -20.0% 7.88 US$39,400
2012-11-21 2012-11-20 PlS Planned sale Lussow Alexander R

Sr. VP, Bus. Dev. & Comm. Op.

Officer
5,000 -20.0%
7.81
US$39,050 		5,000 -20.0% 7.81 US$39,050
2012-11-05 2012-11-01 PlS Planned sale Lussow Alexander R

Sr. VP, Bus. Dev. & Comm. Op.

Officer
5,000 -20.0%
7.52
US$37,600 		5,000 -20.0% 7.52 US$37,600
2012-10-23 2012-10-22 PlS Planned sale Lussow Alexander R

Sr. VP, Bus. Dev. & Comm. Op.

Officer
5,000 -20.0%
7.72
US$38,600 		5,000 -20.0% 7.72 US$38,600
2012-10-05 2012-10-05 PlS Planned sale Lussow Alexander R

Sr. VP, Bus. Dev. & Comm. Op.

Officer
5,000 -20.0%
7.72
US$38,600 		5,000 -20.0% 7.72 US$38,600
2012-09-19 2012-09-18 PlS Planned sale Lussow Alexander R

Sr. VP, Bus. Dev. & Comm. Op.

Officer
5,000 -20.0%
7.57
US$37,850 		5,000 -20.0% 7.57 US$37,850
2012-09-06 2012-09-05 PlS Planned sale Lussow Alexander R

Sr. VP, Bus. Dev. & Comm. Op.

Officer
5,000 -20.0%
7.55
US$37,750 		5,000 -20.0% 7.55 US$37,750
2012-08-20 2012-08-20 PlS Planned sale Lussow Alexander R

Sr. VP, Bus. Dev. & Comm. Op.

Officer
5,000 -20.0%
7.67
US$38,350 		5,000 -20.0% 7.67 US$38,350
2012-08-15 2012-08-13 S Sale LUPINI LINDA

Senior VP, HR & Org. Dev.

Officer
77,007 -83.7%
7.58
US$583,929 		77,007 -83.7% 7.58 US$583,929
2012-08-10 2012-08-08 S Sale LUPINI LINDA

Senior VP, HR & Org. Dev.

Officer
22,993 -60.5%
7.85
US$180,495 		22,993 -60.5% 7.85 US$180,495
2012-08-08 2012-08-08 PlS Planned sale Lussow Alexander R

Sr. VP, Bus. Dev. & Comm. Op.

Officer
5,000 -20.0%
7.92
US$39,600 		5,000 -20.0% 7.92 US$39,600
2012-08-07 2012-08-03 S Sale Jagpal Sukhi

Interim CFO

Officer
67,000 -98.2%
8.19
US$548,730 		67,000 -98.2% 8.19 US$548,730
2012-07-25 2012-07-24 PlS Planned sale Lussow Alexander R

Sr. VP, Bus. Dev. & Comm. Op.

Officer
5,000 -20.0%
8.28
US$41,400 		5,000 -20.0% 8.28 US$41,400
2012-07-11 2012-07-09 S Sale CLARKE C BOYD

Former Director
20,000 -100.0%
7.62
US$152,460 		20,000 -100.0% 7.62 US$152,460
2012-07-11 2012-07-09 S Sale CLARKE C BOYD

Former Director
55,450 -100.0%
7.62
US$422,291 		55,450 -100.0% 7.62 US$422,291
2012-07-10 2012-07-09 PlS Planned sale Lussow Alexander R

Sr. VP, Bus. Dev. & Comm. Op.

Officer
5,000 -20.0%
7.53
US$37,650 		5,000 -20.0% 7.53 US$37,650
2012-06-22 2012-06-21 PlS Planned sale Lussow Alexander R

Sr. VP, Bus. Dev. & Comm. Op.

Officer
5,000 -20.0%
7.65
US$38,250 		5,000 -20.0% 7.65 US$38,250
2012-06-19 2012-06-15 PlS Planned sale Lussow Alexander R

Sr. VP, Bus. Dev. & Comm. Op.

Officer
5,000 -20.0%
7.47
US$37,350 		5,000 -20.0% 7.47 US$37,350
2012-05-18 2012-05-16 B Purchase NB Public Equity K/S Large shareholder
50,000 +0.7%
6.67
US$333,340 		50,000 +0.7% 6.67 US$333,340
2012-05-16 2012-05-15 B Purchase CLARKE C BOYD Non-Executive Director
2,450 +3.4%
6.56
US$16,072 		2,450 +3.4% 6.56 US$16,072
2011-11-30 2011-11-29 S Sale Lussow Alexander R

Sr. VP, Bus. Dev. & Comm. Op.

Officer
20,000 -50.0%
6.73
US$134,522 		20,000 -50.0% 6.73 US$134,522
2011-11-30 2011-11-29 S Sale Lussow Alexander R

Sr. VP, Bus. Dev. & Comm. Op.

Officer
4,400 -9.9%
6.85
US$30,120 		4,400 -9.9% 6.85 US$30,120
2011-11-30 2011-11-28 S Sale Lussow Alexander R

Sr. VP, Bus. Dev. & Comm. Op.

Officer
5,600 -21.9%
7.03
US$39,361 		5,600 -21.9% 7.03 US$39,361
2011-11-23 2011-11-23 B Purchase Lussow Alexander R

Sr. VP, Bus. Dev. & Comm. Op.

Officer
1,300 +7.0%
6.78
US$8,813 		1,300 +7.0% 6.78 US$8,813
2011-11-23 2011-11-23 B Purchase Lussow Alexander R

Sr. VP, Bus. Dev. & Comm. Op.

Officer
2,200 +13.3%
6.77
US$14,897 		2,200 +13.3% 6.77 US$14,897
2011-11-23 2011-11-23 B Purchase Lussow Alexander R

Sr. VP, Bus. Dev. & Comm. Op.

Officer
1,500 +10.0%
6.76
US$10,143 		1,500 +10.0% 6.76 US$10,143
2011-11-23 2011-11-22 B Purchase Lussow Alexander R

Sr. VP, Bus. Dev. & Comm. Op.

Officer
400 +2.7%
6.96
US$2,783 		400 +2.7% 6.96 US$2,783
Explore more

More insider trading research around Novelion Therapeutics Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America